Jaguar Health (JAGX) Change in Receivables (2015 - 2026)
Jaguar Health's (JAGX) quarterly Change in Receivables came in at -$1.5 million in Q1 2026, down 377.96% year-on-year from $522736.1 in Q1 2025, and down 1829.76% on a QoQ basis from $84000.0 in Q4 2025.
Jaguar Health (JAGX) Change in Receivables (2015 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 12 years of Change in Receivables data on file, last reported at -$1.5 million in Q1 2026.
- On a quarterly basis, Change in Receivables fell 377.96% year-over-year to -$1.5 million in Q1 2026; TTM through Mar 2026 was -$1.2 million, a 299.65% decrease from a year earlier, with the FY2025 full-year figure at -$6000.0, up 98.64% from the prior year.
- Change in Receivables for Q1 2026 stood at -$1.5 million, down from $84000.0 in the prior quarter.
- Over the last five years, Change in Receivables for JAGX reached as high as $410000.0 in Q2 2023 and fell as low as -$1.5 million in Q1 2026.
- Historically, Change in Receivables has averaged -$96529.4 across 5 years, with a median of $54000.0 in 2022.
- Across the five-year window, Change in Receivables tumbled 1137.21% in 2023 and soared 628.0% in 2025, its largest moves.
- Year by year, Change in Receivables stood at $54000.0 in 2022, then soared by 442.59% to $293000.0 in 2023, then fell by 5.12% to $278000.0 in 2024, then sank by 69.78% to $84000.0 in 2025, then sank by 1829.76% to -$1.5 million in 2026.
- Per Business Quant data, the three most recent Change in Receivables figures were -$1.5 million in Q1 2026, $84000.0 in Q4 2025, and $264000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn | 75.30 Mn |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn | -39.80 Mn |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn | -1.20 Mn |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn | 110.42 Mn |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - | - |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn | -1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.45 Mn |
| Mar 31, 2026 | -1.45 Mn |
| Dec 31, 2025 | 84,000.00 |
| Dec 31, 2025 | 84,000.00 |
| Sep 30, 2025 | 264,000.00 |
| Sep 30, 2025 | 264,000.00 |
| Jun 30, 2025 | -50,000.00 |
| Jun 30, 2025 | -50,000.00 |
| Mar 31, 2025 | -304,000.00 |
| Mar 31, 2025 | -304,000.00 |
| Dec 31, 2024 | 278,000.00 |
| Dec 31, 2024 | 278,000.00 |
| Sep 30, 2024 | -50,000.00 |
| Sep 30, 2024 | -50,000.00 |
| Jun 30, 2024 | -213,000.00 |
| Jun 30, 2024 | -213,000.00 |
| Mar 31, 2024 | -455,000.00 |
| Mar 31, 2024 | -455,000.00 |
| Dec 31, 2023 | 293,000.00 |
| Dec 31, 2023 | 293,000.00 |